The expression levels of inflammatory cytokines and chemokines (e.g., TNFα, IL-6, CXCL1, CXCL2, CXCR2, CCL2) in crush syndrome were significantly suppressed in TPEN-treated group (Fig. 3i). This evidence concerns the gene CCL2 and Crush Syndrome.